# An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)

> **NCT01604252** · — · TERMINATED · sponsor: **Genentech, Inc.** · enrollment: 503 (actual)

## Conditions studied

- Basal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01604252
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06-20
- **Primary completion:** 2017-04-28
- **Final completion:** 2017-04-28
- **Target enrollment:** 503 (ACTUAL)
- **Why stopped:** The study was terminated early by the Sponsor due to the high rate of discontinuation of subjects unrelated to patient safety.
- **Last updated:** 2017-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01604252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01604252, "An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01604252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*